CX 2018: Ulf Teichgräber discusses EffPAC trial 12-month results

401

Ulf Teichgräber, Jena, Germany, discusses the EffPAC trial 12-month results which were presented for the first time at CX 2018

(Visited 114 times, 1 visits today)

LEAVE A REPLY

Please enter your comment!
Please enter your name here